MR Vascular Fingerprinting with Hybrid Gradient–Spin Echo Dynamic Susceptibility Contrast MRI for Characterization of Microvasculature in Gliomas

Krishnapriya Venugopal*, Fatemeh Arzanforoosh, Daniëlle van Dorth, Marion Smits, Matthias J.P. van Osch, Juan A. Hernandez-Tamames, Esther A.H. Warnert, Dirk H.J. Poot

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

2 Citations (Scopus)
35 Downloads (Pure)

Abstract

Characterization of tumor microvasculature is important in tumor assessment and studying treatment response. This is possible by acquiring vascular biomarkers with magnetic resonance imaging (MRI) based on dynamic susceptibility contrast (DSC). We propose magnetic resonance vascular fingerprinting (MRVF) for hybrid echo planar imaging (HEPI) acquired during the first passage of the contrast agent (CA). The proposed approach was evaluated in patients with gliomas, and we simultaneously estimated vessel radius and relative cerebral blood volume. These parameters were also compared to the respective values estimated using the previously introduced vessel size imaging (VSI) technique. The results of both methods were found to be consistent. MRVF was also found to be robust to noise in the estimation of the parameters. DSC-HEPI-based MRVF provides characterization of microvasculature in gliomas with a short acquisition time and can be further improved in several ways to increase our understanding of tumor physiology.

Original languageEnglish
Article number2180
JournalCancers
Volume15
Issue number7
DOIs
Publication statusPublished - 2023

Keywords

  • cerebral blood volume
  • dynamic susceptibility contrast imaging
  • glioma
  • MR vascular fingerprinting
  • vascular biomarkers
  • vessel radius
  • vessel size imaging

Fingerprint

Dive into the research topics of 'MR Vascular Fingerprinting with Hybrid Gradient–Spin Echo Dynamic Susceptibility Contrast MRI for Characterization of Microvasculature in Gliomas'. Together they form a unique fingerprint.

Cite this